Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy

ConclusionsThe preliminary results of the current study challenge the assumption that alcohol cue-reactivity alone can be used as an early efficacy indicator for AUD pharmacotherapy development. These findings suggest that a wider range of early efficacy indicators and experimental paradigms be considered for Phase II testing of novel compounds.
Source: Psychopharmacology - Category: Psychiatry Source Type: research